Pharmacokinetics and pharmacodynamics of intranasal insulin spray (Nasulin™) administered to healthy male volunteers: Influence of the nasal cycle

Journal of Diabetes Science and Technology

Volumn 2, Issue 6, 2008, Pages 1054-1060

  Leary, Andrew C ^a,b   Dowling, Muiris ^b   Cussen, Kathleen ^b   O'Brien, Jackie ^b   Stote, Robert M ^c  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b Shandon Clinic Cork Ireland   (Ireland)

^c Bentley Pharmaceuticals Inc   (United States)

Author keywords

Insulin kinetics; Intranasal insulin; Nasal cycle; Plasma glucose

Indexed keywords

EID: 67649140570     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229680800200613     Document Type: Article

References (14)

1. Leary AC, Stote RM, Breedt HJ, O'Brien J, Buckley B. Pharmacokinetics and pharmacodynamics of intranasal insulin administered to healthy subjects in escalating doses. Diabetes Technol Ther. 2005;7(1):124-30.
2. Drejer K, Vaag A, Bech K, Hansen P, Sørensen AR, Mygind N. Intranasal administration of insulin with phospholipid as absorption enhancer: pharmacokinetics in normal subjects. Diabet Med. 1992;9(4):335-40.
3. Haruta S, Hanafusa T, Fukase H, Miyajima H, Oki T. An effective absorption behavior of insulin for diabetic treatment following intranasal delivery using porous spherical calcium carbonate in monkeys and healthy human volunteers. Diabetes Technol Ther. 2003;5(1):1-9.
4. Paquot N, Scheen AJ, Franchimont P, Lefebvre PJ. The intra-nasal administration of insulin induces significant hypoglycaemia and classical counterregulatory hormonal responses in normal man. Diabete Metab. 1988;14(1):31-6.
5. Leary AC, Stote RM, Cussen K, O'Brien J, Leary WP, Buckley B. Pharmacokinetics and pharmacodynamics of intranasal insulin administered to patients with type 1 diabetes: a preliminary study. Diabetes Technol Ther. 2006;8(1):81-8.
6. Eccles R. A role for the nasal cycle in respiratory defence. Eur Respir J. 1996;9(2):371-6.
7. Newman SP, Steed KP, Hardy JG, Wilding IR, Hooper G, Sparrow RA. The distribution of an intranasal insulin formulation in healthy volunteers: effect of different administration techniques. J Pharm Pharmacol. 1994;46(8):657-60.
8. Nolte MS, Taboga C, Salamon E, Moses A, Longenecker J, Flier J, Karam JH. Biological activity of nasally administered insulin in normal subjects. Horm Metab Res. 1990;22(3):170-4.
9. Jacobs MA, Schreuder RH, Jap-A-Joe K, Nauta JJ, Andersen PM, Heine RJ. The pharmacodynamics and activity of intranasally administered insulin in healthy male volunteers. Diabetes. 1993;42(11):1649-55.
10. Pontiroli AE, Alberetto M, Secchi A, Dossi G, Bosi I, Pozza G. Insulin given intranasally induces hypoglycaemia in normal and diabetic subjects. Br Med J (Clin Res Ed). 1982;284(6312):303-6.
11. Moses AC, Gordon GS, Carey MC, Flier JS. Insulin administered intranasally as an insulin-bile salt aerosol. Effectiveness and reproducibility in normal and diabetic subjects. Diabetes. 1983;32(11):1040-7.
12. Salzman R, Manson JE, Griffing GT, Kimmerle R, Ruderman N, McCall A, Stoltz EI, Mullin C, Small D, Armstrong J, Melba JC. Intranasal aerosolized insulin: mixed meal studies and long-term use in type 1 diabetes. N Engl J Med. 1985;312(17):1078-84.
13. Sinay IR, Schlimovich S, Damilano S, Cagide AL, Faingold MC, Facco EB, Gurfinkiel MS, Arias P. Intranasal insulin administration in insulin dependent diabetes: reproducibility of its absorption and effects. Horm Metab Res. 1990;22(5):307-8.
14. Hinchcliffe M, Illum L. Intranasal insulin delivery and therapy. Adv Drug Deliv Rev. 1999;35(2-3):199-234.